VenBio is a next-generation investment firm, partnering with life science leaders to invest in novel medicines and game-changing technologies in the advancement of health care.
VenBio was established with the intention of creating and implementing a new model of life sciences investing.
Fundamentally, venBio believes that integrating and aligning all key stakeholders interest is critical to long-term success.
Our investment teams, comprised of industry experts, partner with and invest in emerging biotechnology, life sciences and specialty pharmaceutical companies globally.
With a presence in San Francisco and New York, venBio manages both a Long / Short Equity Hedge Fund strategy along with Venture Capital Funds which are backed by leading life sciences companies and qualified financial investors.
Our investment focus is oriented around clinical stage private and public small and mid-capitalization companies with a therapeutic product and to a lesser extent medical technologies that enable better care for patients.
Our organizational focus is to deliver financial, ethical and strategic returns.